Ignite Creation Date:
2025-12-25 @ 3:28 AM
Ignite Modification Date:
2025-12-26 @ 2:09 AM
Study NCT ID:
NCT03403205
Status:
TERMINATED
Last Update Posted:
2024-06-17
First Post:
2017-12-19
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Efficacy and Safety of ALXN1840 Administered for 48 Weeks Versus Standard of Care in Participants With Wilson Disease
Sponsor:
Alexion Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-02-22
Start Date Type:
ACTUAL
Primary Completion Date:
2023-06-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-06-30
Completion Date Type:
ACTUAL
First Submit Date:
2017-12-19
First Submit QC Date:
None
Study First Post Date:
2018-01-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-09-13
Results First Submit QC Date:
None
Results First Post Date:
2023-10-10
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2022-01-25
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2024-06-14
Last Update Post Date:
2024-06-17
Last Update Post Date Type:
ACTUAL